Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China

Table 2 Multivariable Cox analysis for patient and graft survival in the original cohort (n = 1071)

	Patient survival				Graft survival
Equation variable	P value	HR	95%CI		P value	HR	95%CI
Recipient
BMI	0.001	1.006	1.002	1.010	0.001	1.007	1.002	1.011
MELD	0.942	1.002	0.948	1.059	0.912	1.003	0.949	1.059
CTP	0.429	1.049	0.835	1.263	0.398	1.046	0.834	1.258
HBsAb (negative vs positive)	0.208	1.058	0.768	1.347	0.258	1.027	0.739	1.374
Operation
Anhepatic phase (min)	0.271	1.003	0.997	1.01	0.169	1.004	0.998	1.011
RBC transfusion (U)	0.018	1.055	1.009	1.104	0.021	1.052	1.006	1.103
After operation
Mechanical ventilation (h)	0.002	1.003	1.001	1.006	0.004	1.004	1.001	1.006
Postoperative HBV infection (negative vs positive)	0.502	0.597	0.132	2.695	0.490	0.527	0.118	2.340
Donor
Age	0.215	1.015	0.991	1.042	0.155	1.018	0.992	1.045
AST (IU/L)	0.65	1.002	0.993	1.011	0.563	1.002	0.994	1.011
Na (mmol/L)	0.243	1.016	0.988	1.045	0.408	1.011	0.983	1.041
Anti HBc-positive (negative vs positive)	0.675	1.175	0.551	2.505	0.982	1.008	0.480	2.118

HR: Hazard ratio; CTP score: Child-Pugh score; WIT: Warm ischemic time Na: Donor’s serum Na⁺ concentration.